Shots:
The US FDA has approved Jobevne, a biosimilar version of Avastin (bevacizumab) for IV administration
Approval was based on extensive data showing Jobevne is similar to Avastin in PK, safety, efficacy, structure, & function across clinical & analytical studies
Jobevne (VEGF inhibitor) is marketed under the brand name Abevmy in the EU & Canada,…
Shots: 
Under the terms of the agreement, Sandoz received the exclusive right to commercialize and distribute Ogivri, the biosimilar version of Herceptin & Abevmy, the biosimilar version of Avastin, across Australia for the treatment of various cancer indications Â
Additionally, Sandoz AG will be held responsible to distribute Biocon’s biosimilar versions of trastuzumab and bevacizumab across Australia…

